Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Non-Current Liabilities (2016 - 2026)

Ironwood Pharmaceuticals' Total Non-Current Liabilities history spans 14 years, with the latest figure at $637.1 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities changed 0.31% to $637.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $637.1 million, a 0.31% change, with the full-year FY2025 number at $637.1 million, changed 0.31% from a year prior.
  • Total Non-Current Liabilities hit $637.1 million in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from $638.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for IRWD hit a ceiling of $919.0 million in Q2 2023 and a floor of $436.3 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $587.9 million across 5 years, with a median of $594.6 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 110.62% in 2023 and later fell 25.72% in 2024.
  • Tracing IRWD's Total Non-Current Liabilities over 5 years: stood at $517.5 million in 2021, then dropped by 15.29% to $438.4 million in 2022, then grew by 1.67% to $445.7 million in 2023, then surged by 42.51% to $635.1 million in 2024, then grew by 0.31% to $637.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for IRWD at $637.1 million in Q4 2025, $638.0 million in Q3 2025, and $628.6 million in Q2 2025.